PRESS RELEASE published on 12/22/2025 at 15:20, 6 months 3 days ago Form 8.3 - The Vanguard Group, Inc.: International Personal Finance plc The Vanguard Group, Inc. discloses a 1.13% stake in International Personal Finance plc as of 19 Dec 2025, with recent sale of 10p ordinary shares Vanguard Group Financial Disclosure Stake Disclosure Share Sale International Personal Finance Plc
PRESS RELEASE published on 12/22/2025 at 15:20, 6 months 3 days ago Form 8.3 - The Vanguard Group, Inc.: NCC Group plc The Vanguard Group, Inc. discloses 4.71% stake in NCC Group plc as of 19 Dec 2025. Sale of 1p ordinary securities at 1.44 GBP disclosed on 22 Dec 2025 The Vanguard Group, Inc. Financial Disclosure Stake Disclosure Securities Sale NCC Group Plc
PRESS RELEASE published on 12/22/2025 at 15:19, 6 months 3 days ago Form 8.3 - The Vanguard Group, Inc.: Unite Group plc, The The Vanguard Group, Inc. discloses a 4.97% stake in Unite Group plc, The on 19 December 2025 as per Form 8.3 under the Takeover Code Form 8.3 The Vanguard Group Takeover Code Stake Disclosure Unite Group Plc
BRIEF published on 12/19/2025 at 14:59, 6 months 6 days ago The Vanguard Group Discloses Position in American Axle & Manufacturing Form 8.3 Takeover Code Vanguard Group Securities Position American Axle
BRIEF published on 12/19/2025 at 14:59, 6 months 6 days ago Le groupe Vanguard dévoile sa participation dans American Axle & Manufacturing Groupe Vanguard Code De Prise De Contrôle Formulaire 8.3 Essieu Américain Position Sur Titres
BRIEF published on 12/19/2025 at 14:58, 6 months 6 days ago The Vanguard Group Discloses Stake in JTC plc Takeover Code Securities Disclosure Vanguard Group Shareholding JTC Plc
BRIEF published on 12/19/2025 at 14:58, 6 months 6 days ago Le groupe Vanguard révèle sa participation dans JTC plc Actionnariat Groupe Vanguard Code De Prise De Contrôle Information Sur Les Valeurs Mobilières JTC Plc
BRIEF published on 12/19/2025 at 14:56, 6 months 6 days ago Vanguard Group Discloses Stakes in Avadel Pharmaceuticals Irish Takeover Panel Vanguard Group Form 8.3 Disclosure Equity Positions Avadel Pharmaceuticals
BRIEF published on 12/19/2025 at 14:56, 6 months 6 days ago Le groupe Vanguard révèle sa participation dans Avadel Pharmaceuticals Groupe Vanguard Positions En Actions Avadel Pharmaceuticals Panel Irlandais Des OPA Déclaration Du Formulaire 8.3
PRESS RELEASE published on 12/19/2025 at 14:54, 6 months 6 days ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc. The Vanguard Group, Inc. discloses a 7.60% ownership position in American Axle & Manufacturing Holdings, Inc. with 9,016,245 relevant securities. Purchases and sales have been reported Securities The Vanguard Group Ownership Position Purchases And Sales American Axle & Manufacturing Holdings
Published on 06/26/2026 at 14:05, 37 minutes ago SouthGobi Announces Voting Results of Annual General Meeting of Shareholders
Published on 06/26/2026 at 14:00, 42 minutes ago Dateline Chairman Invests $1.95 million through Options Exercise
Published on 06/26/2026 at 13:00, 1 hour 42 minutes ago Aclara Secures Tax Exemption Approval of Over US$20 Million For Its U.S. Heavy Rare Earth Separation Facility in Louisiana
Published on 06/26/2026 at 01:40, 13 hours 2 minutes ago UraniumX Announces DTC Eligibility for U.S. Traded Shares
Published on 06/26/2026 at 14:00, 42 minutes ago Hong Kong celebrates surge of global enterprises driving investment and opportunities
Published on 06/26/2026 at 14:00, 42 minutes ago Bitcoin Group SE publishes 2025 Annual Report: Strategic realignment ensures future viability in the dynamic crypto market
Published on 06/26/2026 at 13:32, 1 hour 10 minutes ago Porsche ranks number one in J.D. Power 2026 U.S. Initial Quality Study
Published on 06/26/2026 at 13:30, 1 hour 11 minutes ago Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 0.88 per share
Published on 06/26/2026 at 13:30, 1 hour 12 minutes ago AlphaESS Unveils Expanded Energy Storage Ecosystem for Europe at Intersolar 2026
Published on 06/26/2026 at 07:00, 7 hours 42 minutes ago Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/26/2026 at 07:00, 7 hours 42 minutes ago Améliorer la santé des femmes grâce au diagnostic rapide : bioMérieux dépose auprès de la FDA une demande combinée d’autorisation 510(k) et de dérogation CLIA pour son test BIOFIRE® SPOTFIRE® Vaginitis Panel
Published on 06/25/2026 at 18:45, 19 hours 57 minutes ago Avis Financier Semestriel SFCMC au 30 avril 2026
Published on 06/25/2026 at 18:30, 20 hours 12 minutes ago Avis financier semestriel SIEHM au 30 avril 2026
